Showing results (1-10 of 5,585) with videos related to
Sort By:
Pageof 559
Journal of Cellular and Molecular Medicine|August 10, 2002
Thalidomide as an anti-cancer agentS Kumar, T E Witzig, S V RajkumarCancer Treatment Reviews|September 28, 2000
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myelomaS V Rajkumar, T E WitzigLeukemia|June 17, 2005
CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlationsS Kumar, S V Rajkumar, T Kimlinger, et al.Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.Leukemia|March 23, 1999
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, T E Witzig, et al.Oncogene|November 26, 2009
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugsV Ramakrishnan, M Timm, J L Haug, et al.Bone Marrow Transplantation|November 20, 2003
Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemiaS Kumar, M R Litzow, S V RajkumarCancer Chemotherapy and Pharmacology|October 6, 2001
Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphomaT E WitzigMayo Clinic Proceedings|September 1, 1994
Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applicationsT E WitzigPageof 559